126 related articles for article (PubMed ID: 27020505)
21. New models to predict depth of infiltration in endometrial carcinoma based on transvaginal sonography.
De Smet F; De Brabanter J; Van den Bosch T; Pochet N; Amant F; Van Holsbeke C; Moerman P; De Moor B; Vergote I; Timmerman D
Ultrasound Obstet Gynecol; 2006 Jun; 27(6):664-71. PubMed ID: 16715466
[TBL] [Abstract][Full Text] [Related]
22. Endometrial cancer during pregnancy: management strategies.
Eriksson AG; Fallaas Dahl G; Nesbakken AJ; Lund KV; Amant F
Int J Gynecol Cancer; 2019 Sep; 29(7):1221-1224. PubMed ID: 31434687
[No Abstract] [Full Text] [Related]
23. [Application of immunohistochemistry in differential diagnosis of endometrial carcinoma].
Wu HW; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):784-8. PubMed ID: 23302346
[No Abstract] [Full Text] [Related]
24. Coexistence of endometrioid adenocarcinoma in atypical polypoid adenomyoma.
Sonoyama A; Kanda M; Ojima Y; Kizaki T; Ohara N
Kobe J Med Sci; 2014 Dec; 60(3):E74-7. PubMed ID: 25612673
[TBL] [Abstract][Full Text] [Related]
25. High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma.
Stelloo E; Nout RA; Naves LC; Ter Haar NT; Creutzberg CL; Smit VT; Bosse T
Gynecol Oncol; 2014 May; 133(2):197-204. PubMed ID: 24556061
[TBL] [Abstract][Full Text] [Related]
26. Misleading CA-125 levels and computed tomography images in an endometrial cancer patient.
Tjalma WA
J Obstet Gynaecol; 2004 Jun; 24(4):470-1. PubMed ID: 15203605
[No Abstract] [Full Text] [Related]
27. Anti-Yo antibody-positive cerebellar degeneration associated with endometrial carcinoma: case report and review of the literature.
Brock S; Ellison D; Frankel J; Davis C; Illidge T
Clin Oncol (R Coll Radiol); 2001; 13(6):476-9. PubMed ID: 11824891
[TBL] [Abstract][Full Text] [Related]
28. The preoperative assessment of deep myometrial invasion by three-dimensional ultrasound versus MRI in endometrial carcinoma.
Saarelainen SK; Kööbi L; Järvenpää R; Laurila M; Mäenpää JU
Acta Obstet Gynecol Scand; 2012 Aug; 91(8):983-90. PubMed ID: 22548292
[TBL] [Abstract][Full Text] [Related]
29. Evolution of a trophoblastic tumor from an endometrioid carcinoma--a morphological and molecular analysis.
Olson MT; Gocke CD; Giuntoli RL; Shih IeM
Int J Gynecol Pathol; 2011 Mar; 30(2):117-20. PubMed ID: 21293290
[TBL] [Abstract][Full Text] [Related]
30. Effect of the percentage of body fat on surgical, clinical and pathological outcomes in women with endometrial cancer.
Kerimoglu OS; Pekin A; Yilmaz SA; Yavas G; Beyhekim F; Demirtaş AA; Dogan NU; İlhan TT; Celik C
J Obstet Gynaecol Res; 2015 Mar; 41(3):449-55. PubMed ID: 25330937
[TBL] [Abstract][Full Text] [Related]
31. Endometrioid endometrial adenocarcinoma recurring as carcinosarcoma.
Shaco-Levy R; Piura B
J Obstet Gynaecol Res; 2008 Apr; 34(2):279-82. PubMed ID: 18412798
[TBL] [Abstract][Full Text] [Related]
32. A Rare Clinical Entity in Bladder Cancer: Paraneoplastic Cerebellar Degeneration.
Anıl H; Karamık K; Ateş M; Yüksel M; Aktaş Y; Erol İ; Yıldız A; Savaş M
Clin Genitourin Cancer; 2017 Oct; 15(5):e863-e865. PubMed ID: 28506560
[No Abstract] [Full Text] [Related]
33. Secretory endometrial adenocarcinoma.
Pandey P; Mittal S; Goel A; Dixit A
J Obstet Gynaecol Can; 2011 May; 33(5):429. PubMed ID: 21639961
[No Abstract] [Full Text] [Related]
34. Comments on "Effects of uterine manipulation on surgical outcomes in laparoscopic management of endometrial cancer: a prospective randomized clinical trial".
Smid AT; Piek JM; Pijnenborg JM
Int J Gynecol Cancer; 2013 Jul; 23(6):980. PubMed ID: 23792598
[No Abstract] [Full Text] [Related]
35. Isolated splenic metastasis of endometrial adenocarcinoma--a case report.
Andrei S; Preda C; Andrei A; Becheanu G; Herlea V; Lupescu I; Popescu I
Chirurgia (Bucur); 2011; 106(6):833-7. PubMed ID: 22308925
[TBL] [Abstract][Full Text] [Related]
36. Local staging of endometrial carcinoma: comparison of transvaginal and intraoperative sonography and gross visual inspection.
Teefey SA; Stahl JA; Middleton WD; Huettner PC; Bernhard LM; Brown JJ; Hildebolt CF; Mutch DG
AJR Am J Roentgenol; 1996 Mar; 166(3):547-52. PubMed ID: 8623626
[TBL] [Abstract][Full Text] [Related]
37. [Histiocytic endometritis. Report of two cases].
Rivasi F; Philippe E
Ann Pathol; 1996; 16(2):112-4. PubMed ID: 8767678
[TBL] [Abstract][Full Text] [Related]
38. Endometrioid adenocarcinoma arising from endometriosis: a case report.
Micha JP; Mendivil AA; Epstein HD; Laflamme LA; Goldstein BH
J Reprod Med; 2011; 56(11-12):507-10. PubMed ID: 22195335
[TBL] [Abstract][Full Text] [Related]
39. Interpretation of diffuse Cdx2 expression in endometrioid adenocarcinoma in the absence of morules.
Wani Y
Histopathology; 2009 Mar; 54(4):495-7. PubMed ID: 19309406
[No Abstract] [Full Text] [Related]
40. [Brachytherapy for endometrial cancers].
Charra-Brunaud C; Mazeron R
Cancer Radiother; 2013 Apr; 17(2):106-10. PubMed ID: 23375394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
